nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—prostate gland—urinary bladder cancer	0.06	0.274	CbGeAlD
Tirofiban—ITGB3—epithelium—urinary bladder cancer	0.0441	0.201	CbGeAlD
Tirofiban—ITGB3—renal system—urinary bladder cancer	0.0409	0.187	CbGeAlD
Tirofiban—ITGB3—female reproductive system—urinary bladder cancer	0.0327	0.15	CbGeAlD
Tirofiban—ITGB3—Elastic fibre formation—LOXL4—urinary bladder cancer	0.0319	0.0552	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—LOXL1—urinary bladder cancer	0.0242	0.0418	CbGpPWpGaD
Tirofiban—ITGA2B—lymph node—urinary bladder cancer	0.0219	0.1	CbGeAlD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—CSF3—urinary bladder cancer	0.0219	0.0378	CbGpPWpGaD
Tirofiban—ITGB3—lymph node—urinary bladder cancer	0.0191	0.0876	CbGeAlD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—MKI67—urinary bladder cancer	0.0169	0.0292	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—CSF3—urinary bladder cancer	0.0168	0.0291	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—PLAU—urinary bladder cancer	0.015	0.0259	CbGpPWpGaD
Tirofiban—Cardiac tamponade—Methotrexate—urinary bladder cancer	0.0137	0.0676	CcSEcCtD
Tirofiban—ITGA2B—L1CAM interactions—CNTN2—urinary bladder cancer	0.0126	0.0217	CbGpPWpGaD
Tirofiban—Haematemesis—Mitomycin—urinary bladder cancer	0.0124	0.0609	CcSEcCtD
Tirofiban—ITGB3—L1CAM interactions—CNTN2—urinary bladder cancer	0.00968	0.0167	CbGpPWpGaD
Tirofiban—ITGA2B—p130Cas linkage to MAPK signaling for integrins—SRC—urinary bladder cancer	0.00947	0.0164	CbGpPWpGaD
Tirofiban—ITGA2B—GRB2:SOS provides linkage to MAPK signaling for Integrins—SRC—urinary bladder cancer	0.00947	0.0164	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00934	0.0162	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—MMP9—urinary bladder cancer	0.00887	0.0153	CbGpPWpGaD
Tirofiban—ITGB3—PECAM1 interactions—SRC—urinary bladder cancer	0.00872	0.0151	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—PLAU—urinary bladder cancer	0.00747	0.0129	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—PLAU—urinary bladder cancer	0.00746	0.0129	CbGpPWpGaD
Tirofiban—ITGB3—p130Cas linkage to MAPK signaling for integrins—SRC—urinary bladder cancer	0.00729	0.0126	CbGpPWpGaD
Tirofiban—ITGB3—GRB2:SOS provides linkage to MAPK signaling for Integrins—SRC—urinary bladder cancer	0.00729	0.0126	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00719	0.0124	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00708	0.0122	CbGpPWpGaD
Tirofiban—Haematuria—Valrubicin—urinary bladder cancer	0.00665	0.0327	CcSEcCtD
Tirofiban—ITGA2B—Signal transduction by L1—EGFR—urinary bladder cancer	0.00634	0.011	CbGpPWpGaD
Tirofiban—ITGB3—Nectin adhesion pathway—CDH1—urinary bladder cancer	0.00628	0.0109	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—JAG1—urinary bladder cancer	0.00626	0.0108	CbGpPWpGaD
Tirofiban—ITGA2B—Ephrin B reverse signaling—SRC—urinary bladder cancer	0.0061	0.0105	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin alphaIIb beta3 signaling—SRC—urinary bladder cancer	0.00592	0.0102	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—urinary bladder cancer	0.00586	0.0101	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—PLAU—urinary bladder cancer	0.00575	0.00994	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—RHOA—urinary bladder cancer	0.00557	0.00964	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00545	0.00943	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—BIRC3—urinary bladder cancer	0.00509	0.0088	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—EGFR—urinary bladder cancer	0.00488	0.00845	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—SRC—urinary bladder cancer	0.00481	0.00832	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—RHOA—urinary bladder cancer	0.00478	0.00827	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—CNTN2—urinary bladder cancer	0.00475	0.00821	CbGpPWpGaD
Tirofiban—ITGB3—Ephrin B reverse signaling—SRC—urinary bladder cancer	0.0047	0.00812	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet Aggregation (Plug Formation)—SRC—urinary bladder cancer	0.0046	0.00795	CbGpPWpGaD
Tirofiban—ITGB3—Integrin alphaIIb beta3 signaling—SRC—urinary bladder cancer	0.00456	0.00788	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP9—urinary bladder cancer	0.00443	0.00766	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—CDH1—urinary bladder cancer	0.00434	0.0075	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—RBX1—urinary bladder cancer	0.00431	0.00745	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—EGFR—urinary bladder cancer	0.00421	0.00729	CbGpPWpGaD
Tirofiban—ITGB3—Nectin adhesion pathway—SRC—urinary bladder cancer	0.00419	0.00725	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—BIRC3—urinary bladder cancer	0.00392	0.00678	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—SRC—urinary bladder cancer	0.0037	0.00641	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—IGF1—urinary bladder cancer	0.0037	0.0064	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—RHOA—urinary bladder cancer	0.00369	0.00637	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—CNTN2—urinary bladder cancer	0.00366	0.00633	CbGpPWpGaD
Tirofiban—ITGB3—Platelet Aggregation (Plug Formation)—SRC—urinary bladder cancer	0.00354	0.00613	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.00353	0.0061	CbGpPWpGaD
Tirofiban—Pain—Carboplatin—urinary bladder cancer	0.00352	0.0173	CcSEcCtD
Tirofiban—Body temperature increased—Valrubicin—urinary bladder cancer	0.00352	0.0173	CcSEcCtD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—SRC—urinary bladder cancer	0.0035	0.00606	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—urinary bladder cancer	0.00347	0.006	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—IGF1—urinary bladder cancer	0.00345	0.00597	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CNTN2—urinary bladder cancer	0.00339	0.00586	CbGpPWpGaD
Tirofiban—ITGB3—Integrin cell surface interactions—CDH1—urinary bladder cancer	0.00334	0.00578	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—TNF—urinary bladder cancer	0.00332	0.00574	CbGpPWpGaD
Tirofiban—Body temperature increased—Carboplatin—urinary bladder cancer	0.00326	0.016	CcSEcCtD
Tirofiban—ITGB3—Arf6 signaling events—EGFR—urinary bladder cancer	0.00325	0.00561	CbGpPWpGaD
Tirofiban—Hypertension—Mitomycin—urinary bladder cancer	0.00324	0.016	CcSEcCtD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—urinary bladder cancer	0.0032	0.00554	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—RHOA—urinary bladder cancer	0.00316	0.00547	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—EGFR—urinary bladder cancer	0.00307	0.00531	CbGpPWpGaD
Tirofiban—Oedema—Mitomycin—urinary bladder cancer	0.00307	0.0151	CcSEcCtD
Tirofiban—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.003	0.0148	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—RHOA—urinary bladder cancer	0.00297	0.00514	CbGpPWpGaD
Tirofiban—Dizziness—Valrubicin—urinary bladder cancer	0.00294	0.0145	CcSEcCtD
Tirofiban—Swelling—Fluorouracil—urinary bladder cancer	0.00294	0.0145	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—IGF1—urinary bladder cancer	0.00285	0.00493	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—urinary bladder cancer	0.00281	0.00485	CbGpPWpGaD
Tirofiban—Headache—Valrubicin—urinary bladder cancer	0.00279	0.0137	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.00272	0.0047	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—SRC—urinary bladder cancer	0.0027	0.00467	CbGpPWpGaD
Tirofiban—Haematemesis—Methotrexate—urinary bladder cancer	0.00268	0.0132	CcSEcCtD
Tirofiban—Nausea—Valrubicin—urinary bladder cancer	0.00264	0.013	CcSEcCtD
Tirofiban—Pain—Mitomycin—urinary bladder cancer	0.00262	0.0129	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—CNTN2—urinary bladder cancer	0.00261	0.00452	CbGpPWpGaD
Tirofiban—Swelling—Etoposide—urinary bladder cancer	0.00255	0.0126	CcSEcCtD
Tirofiban—Haematemesis—Epirubicin—urinary bladder cancer	0.0025	0.0123	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TERT—urinary bladder cancer	0.00248	0.00428	CbGpPWpGaD
Tirofiban—Body temperature increased—Mitomycin—urinary bladder cancer	0.00242	0.0119	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—EGFR—urinary bladder cancer	0.00236	0.00409	CbGpPWpGaD
Tirofiban—Haemoptysis—Epirubicin—urinary bladder cancer	0.00235	0.0116	CcSEcCtD
Tirofiban—Haematemesis—Doxorubicin—urinary bladder cancer	0.00232	0.0114	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—SRC—urinary bladder cancer	0.00231	0.004	CbGpPWpGaD
Tirofiban—Haematuria—Thiotepa—urinary bladder cancer	0.00231	0.0113	CcSEcCtD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—CDKN1A—urinary bladder cancer	0.00225	0.00389	CbGpPWpGaD
Tirofiban—Haemoglobin—Thiotepa—urinary bladder cancer	0.00218	0.0107	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—SRC—urinary bladder cancer	0.00218	0.00377	CbGpPWpGaD
Tirofiban—Haemoptysis—Doxorubicin—urinary bladder cancer	0.00218	0.0107	CcSEcCtD
Tirofiban—Haemorrhage—Thiotepa—urinary bladder cancer	0.00217	0.0107	CcSEcCtD
Tirofiban—ITGA2B—L1CAM interactions—SRC—urinary bladder cancer	0.00214	0.00371	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—SRC—urinary bladder cancer	0.00208	0.00359	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—RHOA—urinary bladder cancer	0.00207	0.00358	CbGpPWpGaD
Tirofiban—Dizziness—Mitomycin—urinary bladder cancer	0.00203	0.00998	CcSEcCtD
Tirofiban—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.00199	0.00981	CcSEcCtD
Tirofiban—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.00196	0.00965	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—RHOA—urinary bladder cancer	0.00195	0.00338	CbGpPWpGaD
Tirofiban—Sweating—Gemcitabine—urinary bladder cancer	0.00195	0.0096	CcSEcCtD
Tirofiban—Chills—Thiotepa—urinary bladder cancer	0.00195	0.00959	CcSEcCtD
Tirofiban—Haematuria—Gemcitabine—urinary bladder cancer	0.00194	0.00954	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CREBBP—urinary bladder cancer	0.00193	0.00334	CbGpPWpGaD
Tirofiban—Headache—Mitomycin—urinary bladder cancer	0.00192	0.00945	CcSEcCtD
Tirofiban—ITGA2B—L1CAM interactions—EGFR—urinary bladder cancer	0.00188	0.00325	CbGpPWpGaD
Tirofiban—Myocardial infarction—Cisplatin—urinary bladder cancer	0.00186	0.00915	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—IGF1—urinary bladder cancer	0.00185	0.0032	CbGpPWpGaD
Tirofiban—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00184	0.00903	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—RHOA—urinary bladder cancer	0.00183	0.00316	CbGpPWpGaD
Tirofiban—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00183	0.00899	CcSEcCtD
Tirofiban—Nausea—Mitomycin—urinary bladder cancer	0.00182	0.00896	CcSEcCtD
Tirofiban—Haemoglobin—Fluorouracil—urinary bladder cancer	0.0018	0.00888	CcSEcCtD
Tirofiban—Haemorrhage—Fluorouracil—urinary bladder cancer	0.0018	0.00884	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—RHOA—urinary bladder cancer	0.00175	0.00303	CbGpPWpGaD
Tirofiban—Bradycardia—Cisplatin—urinary bladder cancer	0.00173	0.00853	CcSEcCtD
Tirofiban—Myocardial infarction—Etoposide—urinary bladder cancer	0.0017	0.00838	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—RHOA—urinary bladder cancer	0.0017	0.00293	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—SRC—urinary bladder cancer	0.00165	0.00286	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.00164	0.00284	CbGpPWpGaD
Tirofiban—Chills—Gemcitabine—urinary bladder cancer	0.00164	0.00806	CcSEcCtD
Tirofiban—Hypertension—Thiotepa—urinary bladder cancer	0.00163	0.00803	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—SRC—urinary bladder cancer	0.00161	0.00279	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—SRC—urinary bladder cancer	0.0016	0.00277	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ERBB2—urinary bladder cancer	0.00157	0.00272	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—SRC—urinary bladder cancer	0.00151	0.00262	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00151	0.00743	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.0015	0.0026	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IFNA2—urinary bladder cancer	0.00146	0.00253	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—HRAS—urinary bladder cancer	0.00146	0.00253	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—EGFR—urinary bladder cancer	0.00145	0.0025	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—PTEN—urinary bladder cancer	0.00144	0.00249	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—CDH1—urinary bladder cancer	0.00143	0.00247	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CCND1—urinary bladder cancer	0.00143	0.00247	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—SRC—urinary bladder cancer	0.00143	0.00247	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—IGF1—urinary bladder cancer	0.00143	0.00247	CbGpPWpGaD
Tirofiban—Chills—Etoposide—urinary bladder cancer	0.0014	0.00689	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—CCND1—urinary bladder cancer	0.00139	0.0024	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—CDKN1A—urinary bladder cancer	0.00138	0.00239	CbGpPWpGaD
Tirofiban—Hypertension—Gemcitabine—urinary bladder cancer	0.00137	0.00675	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—PTEN—urinary bladder cancer	0.00134	0.00232	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—SRC—urinary bladder cancer	0.00134	0.00231	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.00133	0.00231	CbGpPWpGaD
Tirofiban—Pain—Thiotepa—urinary bladder cancer	0.00132	0.00649	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—EP300—urinary bladder cancer	0.00132	0.00228	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—RHOA—urinary bladder cancer	0.00131	0.00226	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.0013	0.00638	CcSEcCtD
Tirofiban—Oedema—Gemcitabine—urinary bladder cancer	0.0013	0.00638	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—SRC—urinary bladder cancer	0.00128	0.00221	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00128	0.00628	CcSEcCtD
Tirofiban—Oedema—Fluorouracil—urinary bladder cancer	0.00128	0.00628	CcSEcCtD
Tirofiban—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00127	0.00625	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—NCOR1—urinary bladder cancer	0.00127	0.00219	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	0.00126	0.00219	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.00126	0.00218	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—KRAS—urinary bladder cancer	0.00125	0.00217	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00125	0.00617	CcSEcCtD
Tirofiban—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00125	0.00615	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—SRC—urinary bladder cancer	0.00124	0.00215	CbGpPWpGaD
Tirofiban—Urticaria—Thiotepa—urinary bladder cancer	0.00122	0.00603	CcSEcCtD
Tirofiban—Body temperature increased—Thiotepa—urinary bladder cancer	0.00122	0.006	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—ERBB2—urinary bladder cancer	0.00121	0.00209	CbGpPWpGaD
Tirofiban—Oedema—Cisplatin—urinary bladder cancer	0.00121	0.00595	CcSEcCtD
Tirofiban—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00121	0.00595	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—MYC—urinary bladder cancer	0.0012	0.00207	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—KRAS—urinary bladder cancer	0.00118	0.00205	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00118	0.00583	CcSEcCtD
Tirofiban—Hypertension—Etoposide—urinary bladder cancer	0.00117	0.00577	CcSEcCtD
Tirofiban—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00117	0.00575	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	0.00116	0.002	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MYC—urinary bladder cancer	0.00115	0.00198	CbGpPWpGaD
Tirofiban—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00114	0.00559	CcSEcCtD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.00113	0.00196	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IFNA2—urinary bladder cancer	0.00113	0.00195	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HDAC4—urinary bladder cancer	0.00113	0.00195	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—HRAS—urinary bladder cancer	0.00113	0.00195	CbGpPWpGaD
Tirofiban—Pain—Gemcitabine—urinary bladder cancer	0.00111	0.00546	CcSEcCtD
Tirofiban—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00111	0.00545	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—KRAS—urinary bladder cancer	0.00111	0.00192	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—RHOA—urinary bladder cancer	0.00111	0.00191	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—CDH1—urinary bladder cancer	0.0011	0.00191	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.0011	0.0019	CbGpPWpGaD
Tirofiban—Pain—Fluorouracil—urinary bladder cancer	0.00109	0.00537	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—EGFR—urinary bladder cancer	0.00109	0.00188	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00108	0.00534	CcSEcCtD
Tirofiban—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00107	0.00527	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—CCND1—urinary bladder cancer	0.00107	0.00185	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—HRAS—urinary bladder cancer	0.00107	0.00184	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PLAU—urinary bladder cancer	0.00104	0.0018	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP9—urinary bladder cancer	0.00104	0.00179	CbGpPWpGaD
Tirofiban—Pain—Cisplatin—urinary bladder cancer	0.00103	0.00509	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—PTEN—urinary bladder cancer	0.00103	0.00178	CbGpPWpGaD
Tirofiban—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00103	0.00505	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ERBB2—urinary bladder cancer	0.00102	0.00177	CbGpPWpGaD
Tirofiban—Dizziness—Thiotepa—urinary bladder cancer	0.00102	0.00502	CcSEcCtD
Tirofiban—Urticaria—Fluorouracil—urinary bladder cancer	0.00101	0.00499	CcSEcCtD
Tirofiban—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00101	0.00496	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—HRAS—urinary bladder cancer	0.00101	0.00174	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CDK4—urinary bladder cancer	0.001	0.00173	CbGpPWpGaD
Tirofiban—Sweating—Methotrexate—urinary bladder cancer	0.000997	0.00491	CcSEcCtD
Tirofiban—Haematuria—Methotrexate—urinary bladder cancer	0.000992	0.00488	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—NCOR1—urinary bladder cancer	0.000977	0.00169	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	0.000972	0.00168	CbGpPWpGaD
Tirofiban—Headache—Thiotepa—urinary bladder cancer	0.000966	0.00475	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—SRC—urinary bladder cancer	0.000957	0.00165	CbGpPWpGaD
Tirofiban—Body temperature increased—Cisplatin—urinary bladder cancer	0.000956	0.0047	CcSEcCtD
Tirofiban—Pain—Etoposide—urinary bladder cancer	0.000947	0.00466	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—GLI1—urinary bladder cancer	0.000944	0.00163	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—urinary bladder cancer	0.000942	0.00163	CbGpPWpGaD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—HRAS—urinary bladder cancer	0.000941	0.00163	CbGpPWpGaD
Tirofiban—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00094	0.00462	CcSEcCtD
Tirofiban—Haemoglobin—Methotrexate—urinary bladder cancer	0.000939	0.00462	CcSEcCtD
Tirofiban—Haemorrhage—Methotrexate—urinary bladder cancer	0.000934	0.0046	CcSEcCtD
Tirofiban—Sweating—Epirubicin—urinary bladder cancer	0.000933	0.00459	CcSEcCtD
Tirofiban—Haematuria—Epirubicin—urinary bladder cancer	0.000928	0.00457	CcSEcCtD
Tirofiban—Nausea—Thiotepa—urinary bladder cancer	0.000916	0.00451	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—PPARG—urinary bladder cancer	0.000909	0.00157	CbGpPWpGaD
Tirofiban—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000891	0.00438	CcSEcCtD
Tirofiban—Bradycardia—Epirubicin—urinary bladder cancer	0.00089	0.00438	CcSEcCtD
Tirofiban—Urticaria—Etoposide—urinary bladder cancer	0.00088	0.00433	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MMP9—urinary bladder cancer	0.000879	0.00152	CbGpPWpGaD
Tirofiban—Haemoglobin—Epirubicin—urinary bladder cancer	0.000878	0.00432	CcSEcCtD
Tirofiban—Body temperature increased—Etoposide—urinary bladder cancer	0.000876	0.00431	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—HRAS—urinary bladder cancer	0.000874	0.00151	CbGpPWpGaD
Tirofiban—Haemorrhage—Epirubicin—urinary bladder cancer	0.000874	0.0043	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—CREBBP—urinary bladder cancer	0.000873	0.00151	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HDAC4—urinary bladder cancer	0.000868	0.0015	CbGpPWpGaD
Tirofiban—Sweating—Doxorubicin—urinary bladder cancer	0.000864	0.00425	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—urinary bladder cancer	0.000859	0.00423	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—CREBBP—urinary bladder cancer	0.000857	0.00148	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—RHOA—urinary bladder cancer	0.000853	0.00148	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	0.000848	0.00147	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IGF1—urinary bladder cancer	0.000846	0.00146	CbGpPWpGaD
Tirofiban—Dizziness—Fluorouracil—urinary bladder cancer	0.000843	0.00415	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—EGFR—urinary bladder cancer	0.000839	0.00145	CbGpPWpGaD
Tirofiban—Chills—Methotrexate—urinary bladder cancer	0.000838	0.00412	CcSEcCtD
Tirofiban—Bradycardia—Doxorubicin—urinary bladder cancer	0.000823	0.00405	CcSEcCtD
Tirofiban—Hypersensitivity—Etoposide—urinary bladder cancer	0.000816	0.00402	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000813	0.004	CcSEcCtD
Tirofiban—Headache—Gemcitabine—urinary bladder cancer	0.000813	0.004	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—SRC—urinary bladder cancer	0.00081	0.0014	CbGpPWpGaD
Tirofiban—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000809	0.00398	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—PLAU—urinary bladder cancer	0.0008	0.00138	CbGpPWpGaD
Tirofiban—Headache—Fluorouracil—urinary bladder cancer	0.000799	0.00393	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000798	0.00138	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—RHOA—urinary bladder cancer	0.00079	0.00137	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—ERBB2—urinary bladder cancer	0.00079	0.00137	CbGpPWpGaD
Tirofiban—Chills—Epirubicin—urinary bladder cancer	0.000784	0.00386	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—RHOA—urinary bladder cancer	0.000775	0.00134	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CDK4—urinary bladder cancer	0.000771	0.00133	CbGpPWpGaD
Tirofiban—Nausea—Gemcitabine—urinary bladder cancer	0.00077	0.00379	CcSEcCtD
Tirofiban—Nausea—Fluorouracil—urinary bladder cancer	0.000758	0.00373	CcSEcCtD
Tirofiban—Dizziness—Etoposide—urinary bladder cancer	0.000732	0.00361	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—ERBB2—urinary bladder cancer	0.000731	0.00126	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GLI1—urinary bladder cancer	0.000728	0.00126	CbGpPWpGaD
Tirofiban—Chills—Doxorubicin—urinary bladder cancer	0.000726	0.00357	CcSEcCtD
Tirofiban—Nausea—Cisplatin—urinary bladder cancer	0.000718	0.00353	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—EGFR—urinary bladder cancer	0.00071	0.00123	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—PPARG—urinary bladder cancer	0.0007	0.00121	CbGpPWpGaD
Tirofiban—Headache—Etoposide—urinary bladder cancer	0.000694	0.00342	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—MMP9—urinary bladder cancer	0.000677	0.00117	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—HRAS—urinary bladder cancer	0.000673	0.00116	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CREBBP—urinary bladder cancer	0.000673	0.00116	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—KRAS—urinary bladder cancer	0.000671	0.00116	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000663	0.00327	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—CREBBP—urinary bladder cancer	0.00066	0.00114	CbGpPWpGaD
Tirofiban—Nausea—Etoposide—urinary bladder cancer	0.000658	0.00324	CcSEcCtD
Tirofiban—Hypertension—Epirubicin—urinary bladder cancer	0.000657	0.00323	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—IGF1—urinary bladder cancer	0.000652	0.00113	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—IL2—urinary bladder cancer	0.00065	0.00112	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00065	0.0032	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—RBX1—urinary bladder cancer	0.000647	0.00112	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000641	0.00316	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—MMP9—urinary bladder cancer	0.000627	0.00108	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—SRC—urinary bladder cancer	0.000624	0.00108	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000621	0.00306	CcSEcCtD
Tirofiban—Oedema—Epirubicin—urinary bladder cancer	0.000621	0.00306	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—TSC1—urinary bladder cancer	0.000609	0.00105	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RHOA—urinary bladder cancer	0.000609	0.00105	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000608	0.00299	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—urinary bladder cancer	0.000608	0.00299	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.0006	0.00295	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—RHOA—urinary bladder cancer	0.000597	0.00103	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EP300—urinary bladder cancer	0.000595	0.00103	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—EP300—urinary bladder cancer	0.000583	0.00101	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JAG1—urinary bladder cancer	0.000579	0.001	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SRC—urinary bladder cancer	0.000578	0.001	CbGpPWpGaD
Tirofiban—Oedema—Doxorubicin—urinary bladder cancer	0.000574	0.00283	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000574	0.00283	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—HRAS—urinary bladder cancer	0.00057	0.000987	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SRC—urinary bladder cancer	0.000567	0.000981	CbGpPWpGaD
Tirofiban—Pain—Methotrexate—urinary bladder cancer	0.000567	0.00279	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—ERBB2—urinary bladder cancer	0.000563	0.000974	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000562	0.00277	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000555	0.00273	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—EGFR—urinary bladder cancer	0.000547	0.000946	CbGpPWpGaD
Tirofiban—Pain—Epirubicin—urinary bladder cancer	0.000531	0.00261	CcSEcCtD
Tirofiban—Urticaria—Methotrexate—urinary bladder cancer	0.000527	0.00259	CcSEcCtD
Tirofiban—Body temperature increased—Methotrexate—urinary bladder cancer	0.000524	0.00258	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—KRAS—urinary bladder cancer	0.000517	0.000894	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—urinary bladder cancer	0.000507	0.000877	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—urinary bladder cancer	0.000501	0.000866	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RBX1—urinary bladder cancer	0.000499	0.000862	CbGpPWpGaD
Tirofiban—Urticaria—Epirubicin—urinary bladder cancer	0.000493	0.00243	CcSEcCtD
Tirofiban—Pain—Doxorubicin—urinary bladder cancer	0.000491	0.00242	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—urinary bladder cancer	0.000491	0.00242	CcSEcCtD
Tirofiban—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000489	0.00241	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—MMP9—urinary bladder cancer	0.000483	0.000836	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—urinary bladder cancer	0.000483	0.000835	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—urinary bladder cancer	0.000479	0.000828	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—urinary bladder cancer	0.00047	0.000813	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—S100B—urinary bladder cancer	0.000469	0.000811	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TSC1—urinary bladder cancer	0.000469	0.000811	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EP300—urinary bladder cancer	0.000458	0.000792	CbGpPWpGaD
Tirofiban—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000457	0.00225	CcSEcCtD
Tirofiban—Urticaria—Doxorubicin—urinary bladder cancer	0.000456	0.00225	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000454	0.00224	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—EP300—urinary bladder cancer	0.000449	0.000777	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JAG1—urinary bladder cancer	0.000446	0.000772	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SRC—urinary bladder cancer	0.000446	0.000771	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—HRAS—urinary bladder cancer	0.000439	0.00076	CbGpPWpGaD
Tirofiban—Dizziness—Methotrexate—urinary bladder cancer	0.000439	0.00216	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—SRC—urinary bladder cancer	0.000437	0.000756	CbGpPWpGaD
Tirofiban—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000423	0.00208	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—NCOR1—urinary bladder cancer	0.000422	0.00073	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—urinary bladder cancer	0.000418	0.000722	CbGpPWpGaD
Tirofiban—Headache—Methotrexate—urinary bladder cancer	0.000416	0.00205	CcSEcCtD
Tirofiban—Dizziness—Epirubicin—urinary bladder cancer	0.000411	0.00202	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—HRAS—urinary bladder cancer	0.000407	0.000704	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HRAS—urinary bladder cancer	0.000399	0.000691	CbGpPWpGaD
Tirofiban—Nausea—Methotrexate—urinary bladder cancer	0.000394	0.00194	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—EGFR—urinary bladder cancer	0.000391	0.000675	CbGpPWpGaD
Tirofiban—Headache—Epirubicin—urinary bladder cancer	0.000389	0.00191	CcSEcCtD
Tirofiban—Dizziness—Doxorubicin—urinary bladder cancer	0.00038	0.00187	CcSEcCtD
Tirofiban—ITGB3—Developmental Biology—TNF—urinary bladder cancer	0.000372	0.000643	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TERT—urinary bladder cancer	0.000372	0.000643	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—urinary bladder cancer	0.000369	0.000638	CbGpPWpGaD
Tirofiban—Nausea—Epirubicin—urinary bladder cancer	0.000369	0.00182	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—KRAS—urinary bladder cancer	0.000362	0.000626	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—S100B—urinary bladder cancer	0.000361	0.000625	CbGpPWpGaD
Tirofiban—Headache—Doxorubicin—urinary bladder cancer	0.00036	0.00177	CcSEcCtD
Tirofiban—Nausea—Doxorubicin—urinary bladder cancer	0.000341	0.00168	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—FGFR3—urinary bladder cancer	0.000341	0.00059	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—urinary bladder cancer	0.000331	0.000573	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NCOR1—urinary bladder cancer	0.000325	0.000562	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—urinary bladder cancer	0.000322	0.000556	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—urinary bladder cancer	0.000314	0.000542	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—urinary bladder cancer	0.000308	0.000532	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CREBBP—urinary bladder cancer	0.00029	0.000502	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1—urinary bladder cancer	0.000287	0.000496	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TERT—urinary bladder cancer	0.000286	0.000495	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGFR3—urinary bladder cancer	0.000263	0.000455	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RHOA—urinary bladder cancer	0.000263	0.000454	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ESR1—urinary bladder cancer	0.000255	0.000442	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—urinary bladder cancer	0.000243	0.000421	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—urinary bladder cancer	0.000231	0.000399	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CREBBP—urinary bladder cancer	0.000224	0.000387	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1—urinary bladder cancer	0.000221	0.000382	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—urinary bladder cancer	0.00022	0.000381	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—urinary bladder cancer	0.000215	0.000372	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—urinary bladder cancer	0.000209	0.000361	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1A—urinary bladder cancer	0.000208	0.00036	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—urinary bladder cancer	0.000207	0.000359	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RHOA—urinary bladder cancer	0.000202	0.00035	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EP300—urinary bladder cancer	0.000198	0.000342	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SRC—urinary bladder cancer	0.000192	0.000333	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—urinary bladder cancer	0.000187	0.000324	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—urinary bladder cancer	0.000178	0.000307	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—urinary bladder cancer	0.000172	0.000298	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—urinary bladder cancer	0.00017	0.000294	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—urinary bladder cancer	0.000169	0.000292	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—urinary bladder cancer	0.000166	0.000286	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—urinary bladder cancer	0.000161	0.000278	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1A—urinary bladder cancer	0.00016	0.000277	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—urinary bladder cancer	0.00016	0.000276	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—urinary bladder cancer	0.000159	0.000275	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EP300—urinary bladder cancer	0.000152	0.000264	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SRC—urinary bladder cancer	0.000148	0.000256	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—urinary bladder cancer	0.000142	0.000245	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—urinary bladder cancer	0.000135	0.000234	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—urinary bladder cancer	0.000133	0.00023	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—urinary bladder cancer	0.00013	0.000225	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—urinary bladder cancer	0.000123	0.000212	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—urinary bladder cancer	0.000109	0.000189	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—urinary bladder cancer	0.000104	0.00018	CbGpPWpGaD
